CDX-011
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Denise A. Yardley, MD1, Michelle E. Melisko, MD2, Andres Forero, MD3, Brooke R. Daniel, MD4, Alberto J. Montero, MD, MBA5, Troy H…
Case Presentation, Management, and Outcome The patient is a 62-year-old female with stage IV triple-negative invasive ductal…
TPS1110 Background: The internalizable transmembrane glycoprotein NMB (gpNMB) is overexpressed in 20% of BC, including 40% of…
Breast cancer is the most common malignancy in women and significant cause of cancer-related deaths, second only to lung cancer…
Exploiting the highly targeted nature of monoclonal antibodies to deliver selectively to tumor cells a cytotoxic payload is an…
Antibody-drug conjugates (ADCs) represent an exciting and promising therapeutic approach for the treatment of cancers. The US…
The development of monoclonal antibodies as cancer therapeutic agents has improved the outlook for many patients as evidenced by…
Background: GPNMB is an internalizable transmembrane glycoprotein overexpressed in multiple tumor types, including breast cancer…
The World Antibody Drug Conjugate Summit Europe, organized by Biorbis/ Hanson Wade was held in Frankfurt, Germany on February 21…
8525 Background: CDX-011 is an ADC consisting of the potent cellular toxin MMAE conjugated to a fully human monoclonal antibody…